Site menu
Menu
Looking for growth in 2020 and beyond? Here are the latest ASX growth stock ideas, stories and news from our team at Rask Media. We think it’s fair to say that Australia’s ASX growth stocks are some of the best in the world, given their potential for international growth and the fact that many Australian companies also offer their dividends with franking credits.
Daniel Ortisi of Stock Doctor gives us a detailed pre-market commentary on the results of popular small cap RPMGlobal Holdings Ltd (ASX: RUL). Is RUL share price a buy today?
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.22% to 7,729.40.
The S&P/ASX 200 (INDEXASX: XJO) Index rose 8.3 points, or 0.1 per cent, to 7,712.5 on Tuesday, while the broader All Ordinaries (INDEXASX: XAO) rose 9.4 points, or 0.1 per cent, to 7,973.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.11% to 7,712.50.
The benchmark S&P/ASX200 (INDEXASX: XJO) surrendered 142.8 points, to 7,704.2, while the broader All Ordinaries (INDEXASX: XAO) fell 143.9 points, also 1.8 per cent, to 7,963.6.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.82% to 7,704.20.
David Bassanese of Betashares gives the current market update for both S&P/ASX 200 (INDEXASX: XJO) and the S&P 500 (INDEXSP: .INX). Are these share prices undervalued?
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.07% to 7,847.00.
David Bassanese of Betashares gives the current market update for both S&P/ASX 200 (INDEXASX: XJO) and the S&P 500 (INDEXSP: .INX). Are these share prices undervalued?
Daniel Ortisi of Stock Doctor gives us a detailed pre-market commentary on the results of popular small cap RPMGlobal Holdings Ltd (ASX: RUL). Is RUL share price a buy today?
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.22% to 7,729.40.
The S&P/ASX 200 (INDEXASX: XJO) Index rose 8.3 points, or 0.1 per cent, to 7,712.5 on Tuesday, while the broader All Ordinaries (INDEXASX: XAO) rose 9.4 points, or 0.1 per cent, to 7,973.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.11% to 7,712.50.
The benchmark S&P/ASX200 (INDEXASX: XJO) surrendered 142.8 points, to 7,704.2, while the broader All Ordinaries (INDEXASX: XAO) fell 143.9 points, also 1.8 per cent, to 7,963.6.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.82% to 7,704.20.
David Bassanese of Betashares gives the current market update for both S&P/ASX 200 (INDEXASX: XJO) and the S&P 500 (INDEXSP: .INX). Are these share prices undervalued?
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.07% to 7,847.00.
David Bassanese of Betashares gives the current market update for both S&P/ASX 200 (INDEXASX: XJO) and the S&P 500 (INDEXSP: .INX). Are these share prices undervalued?
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024
